Algert Global LLC Nevro Corp Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Nevro Corp stock. As of the latest transaction made, Algert Global LLC holds 57,113 shares of NVRO stock, worth $259,864. This represents 0.01% of its overall portfolio holdings.

Number of Shares

57,113

Previous 216,572 73.63%

Holding current value

$259,864

Previous $1.82 Million 82.51%

% of portfolio

0.01%

Previous 0.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$4.71 - $10.1 $751,051 - $1.61 Million	-159,459 Reduced 73.63%	57,113 $319,000
Q2 2024 Aug 14, 2024	BUY	$7.96 - $13.59 $628,004 - $1.07 Million	78,895 Added 57.3%	216,572 $1.82 Million
Q1 2024 May 14, 2024	BUY	$13.56 - $20.78 $1.87 Million - $2.86 Million	137,677 New	137,677 $1.99 Million
Q3 2023 Nov 13, 2023	SELL	$18.22 - $25.85 $268,380 - $380,770	-14,730 Reduced 33.79%	28,867 $555,000
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $199,734 - $347,195	8,830 Added 25.4%	43,597 $1.11 Million
Q1 2023 May 12, 2023	BUY	$30.17 - $41.11 $21,963 - $29,928	728 Added 2.14%	34,767 $1.26 Million
Q4 2022 Feb 13, 2023	SELL	$36.43 - $49.4 $59,745 - $81,016	-1,640 Reduced 4.6%	34,039 $1.35 Million
Q3 2022 Nov 15, 2022	BUY	$40.66 - $53.03 $845,280 - $1.1 Million	20,789 Added 139.62%	35,679 $1.66 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $608,256 - $1.16 Million	14,890 New	14,890 $653,000
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $228,130 - $341,310	-2,814 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $286,999 - $468,137	2,814 New	2,814 $327,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $161M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Nevro Corp Transaction History